Plus: Next generation IVF, another successful pig-kidney transplant, worm secretions to treat inflammation, a new skin cancer ...
See how Checkpoint Therapeutics, Inc.'s FDA-approved Unloxcyt drug for cSCC is set to disrupt the market with innovative ...
USA News Group News Commentary ? The American Cancer Society recently released its Advances in Oncology ? 2024 Research Highlights report that highlighted how their scientists continued to set the ...
December 16 Lake Street analyst Thomas Flaten raised the firm’s price target on Checkpoint Therapeutics to $7 from $4 and kept a Buy rating on the shares after the company announced FDA approval of ...